It's specific overexpression within various cancers is so pronounced, NEAT1 has garnered implications that it’s expression may be used as a form of biomarker for identifying malignant tissues, as was outlined in a recent study in prostate cancer [77]. This evidence concerns the gene NEAT1 and cancer.